534 related articles for article (PubMed ID: 19460246)
1. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
2. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
6. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.
Munseri PJ; Talbot EA; Mtei L; Fordham von Reyn C
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1037-41. PubMed ID: 18713501
[TBL] [Abstract][Full Text] [Related]
7. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.
Hiransuthikul N; Hiransuthikul P; Nelson KE; Jirawisit M; Paewplot R; Kasak S
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1208-15. PubMed ID: 16438147
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
9. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
Lester R; Hamilton R; Charalambous S; Dwadwa T; Chandler C; Churchyard GJ; Grant AD
AIDS; 2010 Nov; 24 Suppl 5():S45-8. PubMed ID: 21079427
[TBL] [Abstract][Full Text] [Related]
10. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
[TBL] [Abstract][Full Text] [Related]
12. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
Kapoor S; Gupta A; Shah M
Int J Tuberc Lung Dis; 2016 Jan; 20(1):85-92. PubMed ID: 26688533
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Odeke R; Madra P; Hitimana-Lukanika C; Adatu-Engwau F; Blandford JM
Int J Tuberc Lung Dis; 2007 Jul; 11(7):747-54. PubMed ID: 17609049
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
[TBL] [Abstract][Full Text] [Related]
16. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
17. Survey of isoniazid preventive therapy in South Africa, 2011.
Chehab JC; Vilakazi-Nhlapo K; Vranken P; Peters A; Klausner JD
Int J Tuberc Lung Dis; 2012 Jul; 16(7):903-7. PubMed ID: 22583688
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda.
Mugisha B; Bock N; Mermin J; Odeke RM; Miller B; Adatu-Engwau F; Granich R; Bunnell R
Int J Tuberc Lung Dis; 2006 Jul; 10(7):761-7. PubMed ID: 16848338
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of HIV-associated tuberculosis in rural Cambodia.
Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980
[TBL] [Abstract][Full Text] [Related]
20. HIV-related tuberculosis: how well are we doing with current control efforts?
Maher D; Borgdorff M; Boerma T
Int J Tuberc Lung Dis; 2005 Jan; 9(1):17-24. PubMed ID: 15675545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
